Additionally, VCP has been implicated in promoting EMT through the TGF-β1/Smad2/3 signaling pathway, while its inhibition attenuates osteosarcoma cell invasion and metastasis [76]. This evidence concerns the gene SMAD2 and osteosarcoma.